Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways

Digestive Diseases

Volumn 28, Issue 6, 2010, Pages 715-721

  Kojima, Soichi ^a,b   Kuo, Ting Fang ^a,b   Tatsukawa, Hideki ^a   Hirose, Shigehisa ^b  

^a RIKEN   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Apoptosis; Endoplasmic reticulum stress; Liver injury; Sp1; Transglutaminase

Indexed keywords

ALCOHOL; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR SP1;

ALCOHOLIC FATTY LIVER; APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CROSS LINKING; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; LIVER INJURY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CROSS-LINKING REAGENTS; ENDOPLASMIC RETICULUM; FATTY LIVER; FATTY LIVER, ALCOHOLIC; GENE SILENCING; HUMANS; SP1 TRANSCRIPTION FACTOR; STRESS, PHYSIOLOGICAL; TRANSGLUTAMINASES;

EID: 79955601701     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324278     Document Type: Article

References (55)

1. Torres D, Harrison S: Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008; 134: 1682-1698. (Pubitemid 351615413)
2. Varela-Rey M, Embade N, Ariz U, Lu S, Mato J, Martínez-Chantar M: Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol 2009; 41: 969-976.
3. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L: Molecular mechanisms involved in NAFLD progression. J Mol Med 2009; 87: 679-695.
4. Iismaa S, Mearns B, Lorand L, Graham R: Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 2009; 89: 991-1023.
5. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace M, Garofano E, Piredda L, et al: Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 2004; 279: 54783-54792. (Pubitemid 40053223)
6. 2 in alcoholic steatohepatitis. Cell Biol Int 2010; 34: 325-334.
7. Ientile R, Caccamo D, Griffin M: Tissue transglutaminase and the stress response. Amino Acids 2007; 33: 385-394. (Pubitemid 47222963)
8. Chhabra A, Verma A, Mehta K: Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res 2009; 29: 1909-1919.
9. Mehta K, Fok J, Mangala L: Tissue transglutaminase: from biological glue to cell survival cues. Front Biosci 2006; 11: 173-185. (Pubitemid 43253484)
10. 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 2009; 136: 1783-1795.
11. Ji C: Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol 2008; 23(suppl 1):S16-S24. (Pubitemid 351389024)
12. Hotamisligil G, Erbay E: Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8: 923-934.
13. Rao R, Peel A, Logvinova A, del Rio G, Hermel E, Yokota T, Goldsmith P, et al: Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 2002; 514: 122-128. (Pubitemid 34273925)
14. Ito Y, Yamada M, Tanaka H, Aida K, Tsuruma K, Shimazawa M, Hozumi I, et al: Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol Dis 2009; 36: 470-476.
15. Rasheva V, Domingos P: Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 2009; 14: 996-1007.
16. Malhi H, Gores G: Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134: 1641-1654. (Pubitemid 351615416)
17. Wang D, Wei Y, Pagliassotti M: Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006; 147: 943-951. (Pubitemid 43113013)
18. 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 2010; 39: 619-631.
19. Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M: Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem 2002; 277: 16567-16575. (Pubitemid 34967673)
20. 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol 2009; 182: 2084-2092.
21. Mirza A, Liu SL, Frizell E, Zhu J, Maddukuri S, Martinez J, et al: A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF- B. Am J Physiol 1997; 272:G281-G288.
22. Nara K, Nakanishi K, Hagiwara H, Wakita K, Kojima S, Hirose S: Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase. J Biol Chem 1989; 264: 19308-19312. (Pubitemid 19285842)
23. Nagy L, Thomazy VA, Saydak MM, Stein JP, Davies PJ: The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression. Cell Death Differ 1997; 4: 534-547. (Pubitemid 127680688)
24. Ou H, Haendeler J, Aebly MR, Kelly LA, Cholewa BC, Koike G, et al: Retinoic acidinduced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ Res 2000; 87: 881-887.
25. Defacque H, Commes T, Contet V, Sevilla C, Marti J: Differentiation of U937 myelomonocytic cell line by all- trans retinoic acid and 1,25-dihydroxyvitamin D 3 : synergistic effects on tissue transglutaminase. Leukemia 1995; 9: 1762-1767.
26. Shimada J, Suzuki Y, Kim SJ, Wang PC, Matsumura M, Kojima S: Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol Endocrinol 2001; 15: 1677-1692. (Pubitemid 32939299)
27. 1/ BMP4) response element within the mouse tissue transglutaminase gene promoter. J Biol Chem 1998; 273: 12798-12806. (Pubitemid 28246835)
28. Suto N, Ikura K, Sasaki R: Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma HepG2 cells. J Biol Chem 1993; 268: 7469-7473. (Pubitemid 23105644)
29. Kuncio GS, Tsyganskaya M, Zhu J, Liu SL, Nagy L, Thomazy V, et al: TNF-α modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol 1998; 274:G240-G245.
30. 1-adrenergic signal transduction. J Biol Chem 2000; 275: 22213-22219. (Pubitemid 30621803)
31. Esposito C, Caputo I: Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 2005; 272: 615-631. (Pubitemid 40208867)
32. Liu S, Cerione RA, Clardy J: Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 2002; 99: 2743-2747. (Pubitemid 34240531)
33. 2 by GTP. Proc Natl Acad Sci USA 2006; 103: 19683-19688. (Pubitemid 46037492)
34. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM: Targeted inactivation of G h /tissue transglutaminase II. J Biol Chem 2001; 276: 20673-20678.
35. De Laurenzi V, Melino G: Gene disruption of tissue transglutaminase. Mol Cell Biol 2001; 21: 148-155.
36. 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 2007; 132: 1515-1526. (Pubitemid 46627586)
37. Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, et al: Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol 2003; 162: 1293-1303. (Pubitemid 36350673)
38. Diehl AM, Chacon M, Wagner P: The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration. Hepatology 1988; 8: 237-242.
39. Diehl AM, Abdo S, Brown N: Supplemental putrescine reverses ethanol-associated inhibition of liver regeneration. Hepatology 1990; 12: 633-637. (Pubitemid 20349242)
40. Wands JR, Carter EA, Bucher NL, Isselbacher KJ: Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 1979; 77: 528-531. (Pubitemid 9234351)
41. Han J, Park S: Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol Cells 2000; 10: 612-618.
42. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS: Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 2004; 101: 4477-4482. (Pubitemid 38437436)
43. Liu Y: The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 1998; 215: 159-169. (Pubitemid 28359229)
44. Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, et al: c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology 2009; 137: 297-308.
45. Malhi H, Bronk S, Werneburg N, Gores G: Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 2006; 281: 12093-12101. (Pubitemid 43855473)
46. α phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-21103. (Pubitemid 27373968)
47. Todd D, Lee A, Glimcher L: The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008; 8: 663-674.
48. 2005; 307: 935-939. (Pubitemid 40229232)
49. Fok J, Mehta K: Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells. Apoptosis 2007; 12: 1455-1463. (Pubitemid 46988286)
50. Ji C, Kaplowitz N: Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003; 124: 1488-1499. (Pubitemid 36531821)
51. Bleich S, Degner D, Sperling W, Bönsch D, Thürauf N, Kornhuber J: Homocysteine as a neurotoxin in chronic alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 453-464. (Pubitemid 38490756)
52. Talukder I, Borker P, Wollmuth LP: Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating. J Neurosci 2010; 30: 11792-11804.
53. Mukhopadhyay B, Liu J, Osei-Hyiaman D, Godlewski G, Mukhopadhyay P, Wang L, Jeong W, et al: Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid. J Biol Chem 2010; 285: 19002-19011.
54. Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S: CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006; 12: 671-676. (Pubitemid 43865236)
55. Alfos S, Boucheron C, Pallet V, Higueret D, Enderlin V, Béracochéa D, Jaffard R, Higueret P: A retinoic acid receptor antagonist suppresses brain retinoic acid receptor overexpression and reverses a working memory deficit induced by chronic ethanol consumption in mice. Alcohol Clin Exp Res 2001; 25: 1506-1514. (Pubitemid 32976837)